[Importance of repeated immunological stimulation using BCG in the treatment of lepromatous leprosy. New evaluation of 13 patients].
D001500:BCG Vaccine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007271:Injections, Intradermal; D007916:Lepromin / Q000032:analysis; D007918:Leprosy / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D009166:Mycobacterium leprae / Q000302:isolation & purification; D012867:Skin / Q000032:analysis; D012882:Skin Tests; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D014374:Tuberculin Test
D001500:BCG Vaccine; D007136:Immunoglobulins; D013449:Sulfonamides; D013450:Sulfones; D007916:Lepromin
Intérêt d'une stimulation immunitaire par B.C.G. itératif dans le traitement de la lèpre lépromateuse. Nouveau bilan chez treize malades